Complex clinical and microbiological effects on Legionnaires' disease outcone; A retrospective cohort study

Ariela Levcovich, Tsilia Lazarovitch, Jacob Moran-Gilad, Chava Peretz, Eugenia Yakunin, Lea Valinsky, Miriam Weinberger, Ariela Levcovich, Tsilia Lazarovitch, Jacob Moran-Gilad, Chava Peretz, Eugenia Yakunin, Lea Valinsky, Miriam Weinberger

Abstract

Background: Legionnaires' disease (LD) is associated with high mortality rates and poses a diagnostic and therapeutic challenge. Use of the rapid urinary antigen test (UAT) has been linked to improved outcome. We examined the association between the method of diagnosis (UAT or culture) and various clinical and microbiological characteristics and outcome of LD.

Methods: Consecutive patients with pneumonia and confirmation of Legionella infection by a positive UAT and/or a positive culture admitted between the years 2006-2012 to a university hospital were retrospectively studied. Isolated L. pneumophila strains were subject to serogrouping, immunological subtyping and sequence-based typing. Variables associated with 30-day all-cause mortality were analyzed using logistic regression as well as cox regression.

Results: Seventy-two patients were eligible for mortality analyses (LD study group), of whom 15.5 % have died. Diagnosis based on positive L. pneumophila UAT as compared to positive culture (OR = 0.18, 95 % CI 0.03-0.98, p = 0.05) and administration of appropriate antibiotic therapy within 2 hospitalization days as compared to delayed therapy (OR = 0.16, 95 % CI 0.03-0.90, p = 0.04) were independently associated with reduced mortality. When controlling for intensive care unit (ICU) admissions, the method of diagnosis became non-significant. Survival analyses showed a significantly increased death risk for patients admitted to ICU compared to others (HR 12.90, 95 % CI 2.78-59.86, p = 0.001) and reduced risk for patients receiving appropriate antibiotic therapy within the first two admissions days compared to delayed therapy (HR 0.13, 95 % CI 0.04-0.05, p = 0.001). Legionella cultures were positive in 35 patients (including 29 patients from the LD study group), of whom 65.7 % were intubated and 37.1 % have died. Sequence type (ST) ST1 accounted for 50.0 % of the typed cases and ST1, OLDA/Oxford was the leading phenon (53.8 %). Mortality rate among patients in the LD study group infected with ST1 was 18.2 % compared to 42.9 % for non-ST1 genotypes (OR = 0.30, 95 % CI 0.05-1.91, p = 0.23).

Conclusions: The study confirms the importance of early administration of appropriate antibiotic therapy and at the same time highlights the complex associations of different diagnostic approaches with LD outcome. Infection with ST1 was not associated with increased mortality. Genotype effects on outcome mandate examination in larger cohorts.

Figures

Fig. 1
Fig. 1
Flow chart depicting patient selection and inclusion in the analyzed groups. Abbreviations: UAT urinary antigen test, LD Legionnaires’ disease
Fig. 2
Fig. 2
Survival of patients with Legionnaires’ disease as a function of intensive care unit admission. Legend to Fig. 2: Kaplan-Meier short survival curve (all-cause 30-day in-hospital mortality) for patients with Legionnaires' disease who were (red line) or were not (green line) admitted to the intensive care unit (HR = 12.9, 95 % CI 2.780–59.860, p = 0.001 by Cox regression). + Sign denotes censored. Abbreviations: HR Hazard ratio
Fig. 3
Fig. 3
Survival of patients with Legionnaires' disease as a function of appropriate antibiotic therapy. Legend to Fig. 3: Kaplan-Meier short survival curve (all-cause 30-day in-hospital mortality) for patients with Legionnaires' disease who received (green line) or did not receive (red line) appropriate antibiotic therapy within the first two hospitalization days (HR = 0.134, 95 % CI 0.039–0.460, p = 0.001 by Cox regression). + Sign denotes censored. Abbreviations: HR Hazard ratio
Fig. 4
Fig. 4
Genetic relatedness of the characterized L. pneumophila isolates and associated mortality. Legend to Fig. 4: Minimum spanning tree showing the sequence types (ST) of L. pneumophila strains isolated from 30 patients with Legionnaires' disease. Blue circles represent serogroup 1 strains and purple circles represent the non-1 serogroups. ST number is shown inside the circle, and circle size is proportional to the number of strains assigned to each ST. Lighter shades of blue and purple denote fatal cases (all-cause 30-day in-hospital mortality). Line length connecting circles is proportional to the number of allele difference (in parentheses) between the defined STs. NT denotes nontypeable

References

    1. Den Boer JW, Nijhof J, Friesema I. Risk factors for sporadic community-acquired Legionnaires’ disease. A 3-year national case-control study. Public Health. 2006;120:566–571. doi: 10.1016/j.puhe.2006.03.009.
    1. Carratala J, Garcia-Vidal C. An update on Legionella. Curr Opin Infect Dis. 2010;23:152–157. doi: 10.1097/QCO.0b013e328336835b.
    1. Benin AL, Benson RF, Besser RE. Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin Infect Dis. 2002;35:1039–1046. doi: 10.1086/342903.
    1. Mykietiuk A, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R, Manresa F, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis. 2005;40:794–799. doi: 10.1086/428059.
    1. Ginevra C, Duclos A, Vanhems P, Campese C, Forey F, Lina G, et al. Host-related risk factors and clinical features of community-acquired legionnaires disease due to the Paris and Lorraine endemic strains, 1998-2007, France. Clin Infect Dis. 2009;49:184–191. doi: 10.1086/599825.
    1. Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DP. Legionella pneumonia in cancer patients. Medicine (Baltimore) 2008;87:152–159. doi: 10.1097/MD.0b013e3181779b53.
    1. Jespersen S, Sogaard OS, Schonheyder HC, Fine MJ, Ostergaard L. Clinical features and predictors of mortality in admitted patients with community- and hospital-acquired legionellosis: a Danish historical cohort study. BMC Infect Dis. 2010;10:124. doi: 10.1186/1471-2334-10-124.
    1. Mercante JW, Winchell JM. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev. 2015;28:95–133. doi: 10.1128/CMR.00029-14.
    1. Centers for Disease C, Prevention Legionellosis --- United States, 2000-2009. MMWR Morb Mortal Wkly Rep. 2011;60:1083–1086.
    1. European Centre for Disease Prevention and Control . Legionnaires’ disease in Europe, 2012. Stockholm: ECDC; 2014. p. 2014.
    1. Cunha BA, Burillo A, Bouza E. Legionnaires’ disease. Lancet. 2015;38:376-85.
    1. Phin N, Parry-Ford F, Harrison T, Stagg HR, Zhang N, Kumar K, et al. Epidemiology and clinical management of Legionnaires’ disease. Lancet Infect Dis. 2014;14:1011–1021. doi: 10.1016/S1473-3099(14)70713-3.
    1. Mentasti M, Fry NK, Afshar B, Palepou-Foxley C, Naik FC, Harrison TG. Application of Legionella pneumophila-specific quantitative real-time PCR combined with direct amplification and sequence-based typing in the diagnosis and epidemiological investigation of Legionnaires’ disease. Eur J Clin Microbiol Infect Dis. 2012;31:2017–2028. doi: 10.1007/s10096-011-1535-0.
    1. Parr A, Whitney EA, Berkelman RL. Legionellosis on the Rise: A Review of Guidelines for Prevention in the United States. J Public Health Manag Pract. 2015;21:E17–26. doi: 10.1097/PHH.0000000000000123.
    1. European Centre for Disease Prevention and Control . Annual epidemiological report 2014 –Respiratory tract infections. Stockholm: ECDC; 2014. p. 2014.
    1. Lieberman D, Porath A, Schlaeffer F, Lieberman D, Boldur I. Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. Chest. 1996;109:1243–1249. doi: 10.1378/chest.109.5.1243.
    1. Oren I, Zuckerman T, Avivi I, Finkelstein R, Yigla M, Rowe JM. Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control. Bone Marrow Transplant. 2002;30:175–179. doi: 10.1038/sj.bmt.1703628.
    1. Moran-Gilad J, Mentasti M, Lazarovitch T, Huberman Z, Stocki T, Sadik C, et al. Molecular Epidemiology of Legionnaires’ Disease in Israel. Clin Microbiol Infect. 2014;20:690-6.
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. doi: 10.1016/0021-9681(87)90171-8.
    1. Helbig JH, Bernander S, Castellani Pastoris M, Etienne J, Gaia V, Lauwers S, et al. Pan-European study on culture-proven Legionnaires’ disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur J Clin Microbiol Infect Dis. 2002;21:710–716. doi: 10.1007/s10096-002-0820-3.
    1. Ratzow S, Gaia V, Helbig JH, Fry NK, Luck PC. Addition of neuA, the gene encoding N-acylneuraminate cytidylyl transferase, increases the discriminatory ability of the consensus sequence-based scheme for typing Legionella pneumophila serogroup 1 strains. J Clin Microbiol. 2007;45:1965–1968. doi: 10.1128/JCM.00261-07.
    1. Gaia V, Fry NK, Afshar B, Luck PC, Meugnier H, Etienne J, et al. Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila. J Clin Microbiol. 2005;43:2047–2052. doi: 10.1128/JCM.43.5.2047-2052.2005.
    1. Underwood AP, Bellamy W, Afshar B, Fry NK, Harrison TG. Development of an online tool for the European Working Group for Legionella Infections sequence-based typing, including automatic quality assessment and data submission. In: Cianciotto NP, Abu Kwaik Y, Edelstein PH, Fields BS, Geary DF, Harrison TG, Joseph C, Ratcliff RM, Stout JE, Swanson MS, editors. Legionella: state of the art 30 years after its recognition. Washington: ASM Press; 2006. pp. 163–166.
    1. Moran-Gilad J, Lazarovitch T, Mentasti M, Harrison T, Weinberger M, Mordish Y, et al. Humidifier-associated paediatric Legionnaires' disease, Israel, February 2012. Euro Surveill. 2012;17:20293.
    1. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, et al. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore) 2013;92:51–60. doi: 10.1097/MD.0b013e31827f6104.
    1. Garin N, Genne D, Carballo S, Chuard C, Eich G, Hugli O, et al. beta-Lactam monotherapy vs beta-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med. 2014;174:1894–1901. doi: 10.1001/jamainternmed.2014.4887.
    1. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72. doi: 10.1086/511159.
    1. Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR. Guideline adherence and macrolides reduced mortality in outpatients with pneumonia. Respir Med. 2012;106:451–458. doi: 10.1016/j.rmed.2011.11.017.
    1. Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR. Impact of guideline-concordant antibiotics and macrolide/beta-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study. Clin Microbiol Infect. 2013;19:257–264. doi: 10.1111/j.1469-0691.2012.03783.x.
    1. Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther. 2010;32:293–299. doi: 10.1016/j.clinthera.2010.02.006.
    1. McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009;169:1525–1531. doi: 10.1001/archinternmed.2009.259.
    1. Postma DF, van Werkhoven CH, van Elden LJ, Thijsen SF, Hoepelman AI, Kluytmans JA, et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med. 2015;372:1312–1323. doi: 10.1056/NEJMoa1406330.
    1. Lee JS, Fine MJ. The debate on antibiotic therapy for patients hospitalized for pneumonia: where should we go from here? JAMA Intern Med. 2014;174:1901–1903. doi: 10.1001/jamainternmed.2014.3996.
    1. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, et al. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev. 2012;9:CD004418.
    1. Cassier P, Campese C, Le Strat Y, Che D, Ginevra C, Etienne J, et al. Epidemiologic characteristics associated with ST23 clones compared to ST1 and ST47 clones of Legionnaires disease cases in France. New Microbes New Infect. 2015;3:29–33. doi: 10.1016/j.nmni.2014.10.006.
    1. Yu VL, Plouffe JF, Pastoris MC, Stout JE, Schousboe M, Widmer A, et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis. 2002;186:127–128. doi: 10.1086/341087.
    1. Harrison TG, Afshar B, Doshi N, Fry NK, Lee JV. Distribution of Legionella pneumophila serogroups, monoclonal antibody subgroups and DNA sequence types in recent clinical and environmental isolates from England and Wales (2000-2008) Eur J Clin Microbiol Infect Dis. 2009;28:781–791. doi: 10.1007/s10096-009-0705-9.
    1. Vekens E, Soetens O, De Mendonca R, Echahidi F, Roisin S, Deplano A, et al. Sequence-based typing of Legionella pneumophila serogroup 1 clinical isolates from Belgium between 2000 and 2010. Euro Surveill. 2012;17:20302.
    1. Amemura-Maekawa J, Kura F, Helbig JH, Chang B, Kaneko A, Watanabe Y, et al. Characterization of Legionella pneumophila isolates from patients in Japan according to serogroups, monoclonal antibody subgroups and sequence types. J Med Microbiol. 2010;59:653–659. doi: 10.1099/jmm.0.017509-0.
    1. Moran-Gilad J, Prior K, Yakunin E, Harrison TG, Underwood A, Lazarovitch T, et al. Design and application of a core genome multilocus sequence typing scheme for investigation of Legionnaires' disease incidents. Euro Surveill. 2015;20.

Source: PubMed

3
Sottoscrivi